Bluejay Diagnostics reports FY2025 net loss $6.8M; cash $5.2M; needs >$20M additional capital

Bluejay Diagnostics, Inc.

Net loss of ~$6.8M for FY2025; cash and cash equivalents $5.2M; stockholders' equity $6.0M as of Dec 31, 2025.
About 972,000 shares outstanding after full exercise of prefunded warrants; outstanding cash-exercisable warrants with strike above market.
SYMON II clinical study for IL-6 sepsis test progressing; data to support regulatory submission; limited disclosure before submission.
Manufacturing scale-up and supply-chain initiatives on track for commercialization readiness.
Company expects to need at least $20M additional capital through end of FY2027, to be raised in tranches.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Bluejay Diagnostics, Inc. reported the fiscal year ended December 31, 2025 results: net income net losses of approximately $6.8 million.

Period: the fiscal year ended December 31, 2025
Net income: net losses of approximately $6.8 million
Result: reported results

Exact text from the filing

The Company expects to report $5.2 million in cash and cash equivalents and $6.0 million in stockholders’ equity as of December 31, 2025, following successful completion of a $3.8 million warrant-inducement financing in April 2025 and an additional $4.5 million PIPE financing in October 2025. The Company incurred net losses of approximately $6.8 million for the fiscal year ended December 31, 2025.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Bluejay Diagnostics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-024352

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.